HeartBeam, Inc.

BEAT Healthcare Health Information Services

EPS
+33.3%
Free cash flow
−1.24%

Quarter to June 2026, against a year earlier

0.40 0.01 +2.56%
Market cap
$22.2M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions last twelve months

Bought, $m 0.95
Sold, $m 1.08
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — 9 — — — — — — —
Sell 2 — — — — — — — — — — —
Insider Ownership 12.33%

Capital & Financial Ratios $m

Size
Market Cap 22.24
Revenue ttm —
Net income ttm (20.30)
Free cash flow ttm (14.01)
Net debt Q (8.72)
Valuation
P/E 0.00
Forward P/E —
Price / sales 0.00
Forward P/S Powerpack
Price / FCF 0.00
Price / book 2.58
Financial health
Current ratio Q 3.66 (at or above 1.5: strong)
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q (14.00)
Growth
Revenue growth Q —
Operating income growth Q −1.09% (below 0%: shrinking)
EPS, this year +38.17% (at or above 15%: strong)
EPS, next year A +25.22% (at or above 15%: strong)
Revenue, next year A —
EPS, past 5 yrs —
EPS, next 5 yrs A +28.15% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/B against its own 10 years 25.45%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 16 2 4 9
Receivables — — — —
Inventory — — 0 0
Other — — — —
17 3 5 9
2023 2024 2025 Q'26
Payables 1 1 1 1
ST’ Debt — — — —
Other — — — —
1 2 3 2

Compound Annual Growth %

10y 5y 3y
Sales — — —
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 3.12%

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 (0.12) (0.10) — — —
’25 (0.18) (0.15) (0.15) (0.14) (0.62)
’24 (0.17) (0.19) (0.19) (0.18) (0.73)
’23 (0.50) (0.16) (0.13) (0.14) (0.72)
’22 (0.27) (0.43) (0.44) (0.45) (1.59)
’21 (0.06) (0.26) (0.32) (0.40) (1.03)
’20 (0.02) (0.03) (0.09) — (0.29)
Fiscal quarters ending in the months shown.

Revenue $m

Year
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (4) (3) — — —
’25 (4) (3) (3) (3) (14)
’24 (3) (4) (3) (4) (14)
’23 (3) (4) (2) (3) (12)
’22 (2) (2) (3) (3) (10)
’21 0 0 0 (2) (3)
’20 0 0 0 0 (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (4) (4) — — —
’25 (4) (4) (3) (3) (15)
’24 (4) (4) (3) (4) (15)
’23 (3) (4) (2) (3) (12)
’22 (2) (2) (3) (3) (10)
’21 0 0 0 (2) (3)
’20 0 0 0 0 (1)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.7
1Buy 2 3Hold 4 5Sell

Ten years at a glance

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — — — — — — — — — 0 4 13 +577.9%
Gross margin, % — — — — — — — — — — — —
EBT — — — (1) (1) (4) (13) (15) (19) (21) (20) +84.3%
EBT margin, % — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0 pt
Net income — 0 — (1) (1) (4) (13) (15) (19) (21) (20) n/m
Per share, $
Per share, $ Revenue — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 n/m
Earnings — — — (0.16) (0.29) (1.03) (1.59) (0.72) (0.73) (0.62) (0.51) +25.7%
Cash flow — — — (0.06) (0.16) (0.75) (1.22) (0.59) (0.54) (0.41) (0.25) +36.6%
Capex — — — 0.00 0.00 0.00 0.00 (0.01) (0.01) (0.02) (0.02) n/m
Free cash flow — — — (0.06) (0.16) (0.75) (1.22) (0.61) (0.55) (0.43) (0.27) +37.5%
Book value — — — (1.09) (1.31) 3.13 0.29 0.78 0.06 0.08 0.15 n/m
Shares, m — — — 3 4 4 8 20 27 34 40 +46.5%
Valuation, ×
Valuation, × P/E — — — — — — — — — — 0 —
P/S — — — — — — — — — — 0 —
P/B — — — — — — — — — — 0 —
EV/Sales — — — — — — — — — — 0 —
EV/FCF — — — — — — — — — — 0 —
Cash, $m
Cash, $m Operating cash flow — — — 0 (1) (3) (10) (12) (14) (14) (13) +100.1%
Capex — — — — — — — 0 0 (1) (1) +53.1%
Free cash flow — — — 0 (1) (3) (10) (12) (15) (15) (14) +101.5%
Balance, $m
Balance, $m Working capital — — — 0 (5) 13 2 16 1 1 7 n/m
Net debt — — — 3 0 (13) (4) (16) (2) (4) (9) n/m
Shareholders’ equity — — — (4) (5) 13 2 16 2 3 8 n/m
Returns, %
Returns, % ROA — — — (15,314.29) (3,682.76) (63.04) (143.73) (138.30) (190.60) (460.91) (244.27) +14,853.4 pt
ROIC — — — 0.00 0.00 (655.10) 0.00 0.00 0.00 0.00 0.00 0.0 pt
ROE — — — 12.59 25.09 (102.68) (164.24) (159.89) (221.11) (987.32) (328.44) (999.9) pt
People
People Employees — — — — — — 15 15 21 16 — +2.2%
Revenue/emp, $m — — — — — — 0.00 0.00 0.00 0.00 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fundamentals updated 26 Oct 2026

HeartBeam, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
LFMD LifeMD, Inc. $110.4M — (loss-making) — (loss-making) −3.55% (below 0%: shrinking) n/m −247.52% (below 0%: shrinking) 88.82% (15.08%) Compare
CCLD CareCloud, Inc. $91.8M 16.5× 11.0× +8.56% (above 0%: growing) +150.00% (above 0%: growing) −0.44% (below 0%: shrinking) 50.46% 19.50% Compare
DRIO DarioHealth Corp. $26.7M — (loss-making) — (loss-making) −3.58% (below 0%: shrinking) n/m −0.74% (below 0%: shrinking) 61.66% (125.15%) Compare
ONMD OneMedNet Corporation $25.1M — (loss-making) — +88.39% (above 0%: growing) n/m +14.05% (above 0%: growing) (193.49%) (774.32%) Compare
BEAT HeartBeam, Inc. $22.2M — (loss-making) — — n/m −1.24% (below 0%: shrinking) — 0.00%
RNLXY Renalytix plc - Sponsored ADR $17.2M — (loss-making) — +13.73% (above 0%: growing) n/m +17.96% (above 0%: growing) 19.16% (783.91%) Compare
BFRG Bullfrog AI Holdings Inc. $9.1M — (loss-making) — (loss-making) +2,054.00% (above 0%: growing) n/m −5.67% (below 0%: shrinking) 49.63% (658.82%) Compare
HLTHQ Cue Health Inc. $6.9M — (loss-making) — (loss-making) −87.19% (below 0%: shrinking) n/m +50.55% (above 0%: growing) (90.14%) (792.13%) Compare
ACON Aclarion, Inc. $4.5M — (loss-making) — (loss-making) +78.48% (above 0%: growing) n/m −74.22% (below 0%: shrinking) 43.86% (8,164.70%) Compare
Median of peers $21.1M — — +11.15% — −0.59% 46.75% (716.57%)

All 44 Health Information Services stocks →

Pay and ownership Proxy statement filed 18 June 2026

Ownership

Directors and executive officers, together 17.95%
Mark Strome 6.91%
Public Ventures 5.61%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

HeartBeam, Inc. (BEAT) Latest News

21 Sep

Impact 4 · · Business Wire

13 May

Impact 4 · · Benzinga transcript
Impact 4 · · Business Wire
stockrow.com/BEAT · Data as of Oct 26, 2026 · For information only; not investment advice. · © 2026 stockrow.com